CA2255804A1 - Methode antitumorale par administration de derives de partricine - Google Patents
Methode antitumorale par administration de derives de partricine Download PDFInfo
- Publication number
- CA2255804A1 CA2255804A1 CA002255804A CA2255804A CA2255804A1 CA 2255804 A1 CA2255804 A1 CA 2255804A1 CA 002255804 A CA002255804 A CA 002255804A CA 2255804 A CA2255804 A CA 2255804A CA 2255804 A1 CA2255804 A1 CA 2255804A1
- Authority
- CA
- Canada
- Prior art keywords
- antitumoral
- administration
- partricin
- derivatives
- partricin derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NVJUPMZQNWDHTL-MJODAWFJSA-N partricin Chemical class O1C(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC(O2)(O)CC(O)C(C(O)=O)C2CC(O[C@@H]2[C@@H]([C@H](N)[C@@H](O)[C@H](C)O2)O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C(C)C1C(C)CCC(O)CC(=O)C1=CC=C(N)C=C1 NVJUPMZQNWDHTL-MJODAWFJSA-N 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229950007355 partricin Drugs 0.000 abstract 1
- 150000004291 polyenes Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002255804A CA2255804C (fr) | 1998-12-07 | 1998-12-07 | Methode antitumorale par administration de derives de partricine |
| US09/258,822 US6121244A (en) | 1997-09-19 | 1999-02-26 | Antitumoral method by administration of partricin derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002255804A CA2255804C (fr) | 1998-12-07 | 1998-12-07 | Methode antitumorale par administration de derives de partricine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2255804A1 true CA2255804A1 (fr) | 2000-06-07 |
| CA2255804C CA2255804C (fr) | 2009-07-28 |
Family
ID=29425801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002255804A Expired - Fee Related CA2255804C (fr) | 1997-09-19 | 1998-12-07 | Methode antitumorale par administration de derives de partricine |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2255804C (fr) |
-
1998
- 1998-12-07 CA CA002255804A patent/CA2255804C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2255804C (fr) | 2009-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2346011A1 (fr) | Matrices a nanofibres hybrides s'utilisant comme dispositifs de genie tissulaire | |
| CA2287470A1 (fr) | Trifluoromethylalkylamino-triazolopyrimidines fongicides | |
| IL80495A0 (en) | Microbial compositions,their production and their use for treating soil | |
| HN1998000143A (es) | Tetrahidronaftalenos substituidos y compuestos analogos. | |
| CA2026915A1 (fr) | Facteurs de cellule souche | |
| CA2193337A1 (fr) | Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs | |
| CA2361920A1 (fr) | Systeme de transport | |
| CA2428450A1 (fr) | Prothese corporelle | |
| AU6973991A (en) | Therapeutically active chloro substituted benzimidazoles, processes for their preparation as well as their use | |
| FI963103A0 (fi) | Ei-virusvektori | |
| CA2230819A1 (fr) | Medicament comprenant le gene hgf | |
| HK74787A (en) | Anthracycline glycosides | |
| ZA997176B (en) | Derivatives of erythromycin, their preparation process and their use as medicaments. | |
| AU2910289A (en) | Rotator for crane-mounted working implements, especially tree-processing units | |
| DE69920949D1 (de) | Ascomycin enthaltende topische zubereitungen | |
| AU5290199A (en) | Erythromycin derivatives with antibiotic activity | |
| AU8213487A (en) | Anthracycline derivatives having cytostatic activity | |
| MY126362A (en) | Novel pyrimido [1,2-a] indoles | |
| CA2063273A1 (fr) | Surfactants pulmonaires et methodes | |
| AU4391199A (en) | Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose | |
| AU591174B2 (en) | Imidazoles, their preparation and their use as fungicides | |
| CA2358997A1 (fr) | Outil de reduction de frottement et son procede d'utilisation dans un forage | |
| CA2022553A1 (fr) | Contenant en forme de livre pour faire pousser des semis | |
| IE802033L (en) | Dibenzazepine derivatives | |
| NZ243202A (en) | Glycosylated avermectin derivatives; their preparation by fermentation, their use as parasiticides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20131209 |